Retinal vein occlusion coinciding with paracentral acute middle maculopathy in patient with menorrhagia causing life-threatening anemia
International Journal of Ophthalmology · 18.09.2024 · 17 (9) · 1760-1762
DOI: 10.18240/ijo.2024.09.26 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Ophthalmology, erschienen am 18.09.2024. Verfasst von Wen-Yun Lin und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- School of Medicine, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan, China.
- Department of Ophthalmology, Chang Gung Memorial Hospital, Chiayi 61363, Taiwan, China.
- Department of Nursing, Chang Gung University of Science and Technology, Chiayi 61363, Taiwan, China.
- School of Traditional Chinese Medicine, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan, China.
Zitieren
APA
Lin, W. Y., Wang, J. J., & Lai, C. H. (2024). Retinal vein occlusion coinciding with paracentral acute middle maculopathy in patient with menorrhagia causing life-threatening anemia. International Journal of Ophthalmology, 17(9), 1760-1762. https://doi.org/10.18240/ijo.2024.09.26
Vancouver
Lin WY, Wang JJ, Lai CH. Retinal vein occlusion coinciding with paracentral acute middle maculopathy in patient with menorrhagia causing life-threatening anemia. International Journal of Ophthalmology. 2024;17(9):1760-1762. doi:10.18240/ijo.2024.09.26
BibTeX
@article{Lin2024,
author = {Lin, Wen-Yun and Wang, Jin-Jhe and Lai, Chien-Hsiung},
title = {Retinal vein occlusion coinciding with paracentral acute middle maculopathy in patient with menorrhagia causing life-threatening anemia},
journal = {International Journal of Ophthalmology},
year = {2024},
volume = {17},
number = {9},
pages = {1760--1762},
doi = {10.18240/ijo.2024.09.26}
}
EUVIMED